{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:12Z","timestamp":1793633472419,"version":"4.5.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103116","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:29:30Z","timestamp":1790436570000},"page":"103116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights into extracellular vesicles: From biogenesis and tumor immune modulation to their clinical potential in immunotherapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Shuang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3262-2013","authenticated-orcid":false,"given":"Wanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8937-353X","authenticated-orcid":false,"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103116_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41580-025-00922-4","article-title":"Biology and therapeutic potential of extracellular vesicle targeting and uptake","volume":"27","author":"Ripoll","year":"2026","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2026.103116_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/futurepharmacol5030048","article-title":"Extracellular Vesicles as Mediators of Intercellular Communication: Implications for Drug Discovery and Targeted Therapies","volume":"5","author":"Mimi","year":"2025","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.omtn.2026.103116_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-025-02233-w","article-title":"Extracellular vesicles in tumor immunity: mechanisms and novel insights","volume":"24","author":"Kuang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtn.2026.103116_bib5","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.immuni.2024.07.009","article-title":"The biology and function of extracellular vesicles in immune response and immunity","volume":"57","author":"Kalluri","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.103116_bib6","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1038\/s41467-025-64172-w","article-title":"Dendritic cell progenitors engineered to express extracellular-vesicle\u2013internalizing receptors enhance cancer immunotherapy in mouse models","volume":"16","author":"Ghasemi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103116_bib7","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1016\/j.apsb.2025.04.033","article-title":"Extracellular vesicles as biomarkers and drug delivery systems for tumor","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.omtn.2026.103116_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/inmd.70084","article-title":"Extracellular vesicle-based vaccines and immunotherapeutics for treatment of cancer","volume":"4","author":"Tan","year":"2026","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.omtn.2026.103116_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijms23010008","article-title":"The Role of Exosomes in Cancer Progression","volume":"23","author":"Solt\u00e9sz","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.omtn.2026.103116_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/biology12010110","article-title":"Extracellular Vesicles: New Classification and Tumor Immunosuppression","volume":"12","author":"Sheta","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.omtn.2026.103116_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12951-023-01969-1","article-title":"Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials","volume":"21","author":"Yu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2026.103116_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jconrel.2022.09.045","article-title":"Apoptotic bodies for advanced drug delivery and therapy","volume":"351","author":"Zhou","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtn.2026.103116_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41586-021-04234-3","article-title":"MicroRNA sequence codes for small extracellular vesicle release and cellular retention","volume":"601","author":"Garcia-Martin","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103116_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12915-022-01277-4","article-title":"Sorting and packaging of RNA into extracellular vesicles shape intracellular transcript levels","volume":"20","author":"O\u2019Grady","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.omtn.2026.103116_bib15","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201912074","article-title":"The RNA binding protein FMR1 controls selective exosomal miRNA cargo loading during inflammation","volume":"219","author":"Wozniak","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.omtn.2026.103116_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50336-5","article-title":"TRIM25 dictates selective miRNA loading into extracellular vesicles during inflammation","volume":"13","author":"King","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103116_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","article-title":"The roles of extracellular vesicles in the immune system","volume":"23","author":"Buzas","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2026.103116_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103116_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70035","article-title":"Direct delivery of immune modulators to tumour-infiltrating lymphocytes using engineered extracellular vesicles","volume":"14","author":"Lyu","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib20","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3389\/fmicb.2018.01792","article-title":"Characterization of Dendritic Cell-Derived Extracellular Vesicles During Dengue Virus Infection","volume":"9","author":"Martins","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtn.2026.103116_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70068","article-title":"Dendritic Cell Derived-Extracellular Vesicles Engineered to Express Interleukin-12 and Anti-CTLA-4 on Their Surface for Combinational Cancer Immunotherapy","volume":"14","author":"Chen","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2005-01-0220","article-title":"ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming","volume":"106","author":"Segura","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2026.103116_bib23","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/sj.emboj.7601842","article-title":"T cell-induced secretion of MHC class II\u2013peptide complexes on B cell exosomes","volume":"26","author":"Muntasell","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2026.103116_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2014.08.008","article-title":"MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells","volume":"41","author":"Okoye","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.103116_bib25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ni.3868","article-title":"Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor","volume":"18","author":"Maj","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2026.103116_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70118","article-title":"Induced Treg-Derived Extracellular Vesicles Suppress CD4 + T-Cell-Mediated Inflammation and Ameliorate Bone Loss During Periodontitis Partly Through CD73\/Adenosine-Dependent Immunomodulatory Mechanisms","volume":"14","author":"Rojas","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl1698","article-title":"MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis","volume":"17","author":"De Rosa","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.103116_bib28","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41467-025-57367-8","article-title":"HBV-associated hepatocellular carcinomas inhibit antitumor CD8+ T cell via the long noncoding RNA HDAC2-AS2","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103116_bib29","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1172\/JCI98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.103116_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1593834","article-title":"Beyond boundaries: exploring the role of extracellular vesicles in organ-specific metastasis in solid tumors","volume":"16","author":"Nidhi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.103116_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tcb.2025.05.006","article-title":"The role of the immune tumor microenvironment in shaping metastatic dissemination, dormancy, and outgrowth","volume":"36","author":"Grant","year":"2026","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.omtn.2026.103116_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.34697","article-title":"Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment","volume":"154","author":"Alonso-Crisostomo","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2026.103116_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40425-018-0451-6","article-title":"Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion","volume":"6","author":"Ye","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omtn.2026.103116_bib34","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.molcel.2020.05.004","article-title":"Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment","volume":"78","author":"Hou","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.103116_bib35","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.3390\/cancers14194923","article-title":"Spatial Profiling of the Prostate Cancer Tumor Microenvironment Reveals Multiple Differences in Gene Expression and Correlation with Recurrence Risk","volume":"14","author":"Kumar","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.omtn.2026.103116_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2444704","article-title":"Assessment of adenosinergic activity of small extracellular vesicles in plasma of cancer patients and healthy donors","volume":"14","author":"Hong","year":"2025","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtn.2026.103116_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s42003-023-05169-3","article-title":"Small EV in plasma of triple negative breast cancer patients induce intrinsic apoptosis in activated T cells","volume":"6","author":"Mondal","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2026.103116_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41590-017-0043-5","article-title":"Tumor-derived exosomes antagonize innate antiviral immunity","volume":"19","author":"Gao","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2026.103116_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2021.05.032","article-title":"Extracellular vesicles in the tumor immune microenvironment","volume":"516","author":"Hou","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omtn.2026.103116_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111813","article-title":"Liposomes embedded in layer by layer constructs as simplistic extracellular vesicles transfer model","volume":"121","author":"Dom\u00ednguez-Arca","year":"2021","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.omtn.2026.103116_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101771","article-title":"Exosome nanovesicles: A potential carrier for therapeutic delivery","volume":"49","author":"Chavda","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.omtn.2026.103116_bib42","first-page":"228","article-title":"Biomimetic extracellular vesicles derived from chimeric antigen receptor monocytes to treat glioblastoma: An efficient and safe intranasal drug delivery nanoplatform","volume":"52","author":"Cheng","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.omtn.2026.103116_bib43","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1007\/s13346-023-01370-3","article-title":"Extracellular vesicle\u2013based drug delivery in cancer immunotherapy","volume":"13","author":"Najafi","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.omtn.2026.103116_bib44","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/s41598-021-83241-w","article-title":"Selective loss of microvesicles is a major issue of the differential centrifugation isolation protocols","volume":"11","author":"Nigro","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103116_bib45","series-title":"Exosomes","first-page":"23","article-title":"Methods for exosome isolation and characterization","author":"Zhou","year":"2020"},{"key":"10.1016\/j.omtn.2026.103116_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/15476286.2018.1564465","article-title":"Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum","volume":"16","author":"Langevin","year":"2019","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2026.103116_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1490143","article-title":"Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine","volume":"7","author":"Oeyen","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymeth.2015.04.008","article-title":"Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct","volume":"87","author":"Xu","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.omtn.2026.103116_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jbiotec.2011.09.028","article-title":"Protein precipitation by polyethylene glycol: A generalized model based on hydrodynamic radius","volume":"157","author":"Sim","year":"2012","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103116_bib50","series-title":"Protein Chromatography","first-page":"35","article-title":"Immunoaffinity chromatography","author":"Fitzgerald","year":"2010"},{"key":"10.1016\/j.omtn.2026.103116_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biotechadv.2018.11.001","article-title":"Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development","volume":"37","author":"Wang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omtn.2026.103116_bib52","article-title":"Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing","volume":"24","author":"Llorens-Revull","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.omtn.2026.103116_bib53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.20517\/evcna.2024.34","article-title":"Choice of size-exclusion chromatography column affects recovery, purity, and miRNA cargo analysis of extracellular vesicles from human plasma","volume":"5","author":"Bracht","year":"2024","journal-title":"Extracell. Vesicles Circ. Nucl. Acids"},{"key":"10.1016\/j.omtn.2026.103116_bib54","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v5.31655","article-title":"Comparative analysis of EV isolation procedures for miRNAs detection in serum samples","volume":"5","author":"Andreu","year":"2016","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118813","article-title":"Quantitative and qualitative comparison of mRNA loading techniques into extracellular vesicles","volume":"193","author":"Guarro","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2026.103116_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/pr9020356","article-title":"Overview and Update on Methods for Cargo Loading into Extracellular Vesicles","volume":"9","author":"Han","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.omtn.2026.103116_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2024.100052","article-title":"Ultrasonication outperforms electroporation for extracellular vesicle cargo depletion","volume":"4","author":"Chen","year":"2024","journal-title":"Extracell. Vesicle"},{"key":"10.1016\/j.omtn.2026.103116_bib58","article-title":"Strategies for Engineering of Extracellular Vesicles","volume":"24","author":"Danilushkina","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.omtn.2026.103116_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12951-023-01973-5","article-title":"Extracellular vesicles: a rising star for therapeutics and drug delivery","volume":"21","author":"Du","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2026.103116_bib60","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109288","article-title":"Extracellular vesicles and particles impact the systemic landscape of cancer","volume":"41","author":"Lucotti","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2026.103116_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-021-01490-9","article-title":"Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma","volume":"21","author":"Serrat\u00ec","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtn.2026.103116_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1710899","article-title":"Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients","volume":"9","author":"Cordonnier","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib63","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1387706","article-title":"Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma","volume":"7","author":"Tucci","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtn.2026.103116_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12418","article-title":"PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer","volume":"13","author":"Sch\u00f6ne","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.omtn.2026.103116_bib65","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1038\/s41598-021-87575-3","article-title":"Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer","volume":"11","author":"Shimada","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.103116_bib66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13046-022-02379-1","article-title":"Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer","volume":"41","author":"de Miguel-Perez","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2026.103116_bib67","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jtho.2020.05.022","article-title":"Circulating MicroRNAs and Extracellular Vesicle\u2013Containing MicroRNAs as Response Biomarkers of Anti\u2013programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC","volume":"15","author":"Shukuya","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.omtn.2026.103116_bib68","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2147\/OTT.S232453","article-title":"Exosomal MicroRNAs as Liquid Biopsy Biomarkers in Hepatocellular Carcinoma","volume":"13","author":"Wang","year":"2020","journal-title":"OTT"},{"key":"10.1016\/j.omtn.2026.103116_bib69","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jconrel.2022.05.062","article-title":"Engineered extracellular vesicles and their mimetics for cancer immunotherapy","volume":"349","author":"Liu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtn.2026.103116_bib70","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell-Derived Exosomes for Suppressing Tumor Progression and Metastasis","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.103116_bib71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-022-01266-8","article-title":"Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses","volume":"15","author":"Zuo","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omtn.2026.103116_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003747","article-title":"On-Chip Biogenesis of Circulating NK Cell-Derived Exosomes in Non-Small Cell Lung Cancer Exhibits Antitumoral Activity","volume":"8","author":"Kang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.103116_bib73","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3390\/cancers11101560","article-title":"Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.omtn.2026.103116_bib74","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12951-022-01270-7","article-title":"Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2026.103116_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtn.2026.103116_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis Onc"},{"key":"10.1016\/j.omtn.2026.103116_bib77","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41467-020-20723-x","article-title":"Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103116_bib78","article-title":"Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omtn.2026.103116_bib79","first-page":"206","article-title":"Reprogramming exosomes for immunity-remodeled photodynamic therapy against non-small cell lung cancer","volume":"39","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.omtn.2026.103116_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120935","article-title":"Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy","volume":"308","author":"Ahmadi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.omtn.2026.103116_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1476737","article-title":"Extracellular vesicles for cancer therapy: potential, progress, and clinical challenges","volume":"12","author":"Ren","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103116_bib82","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1002\/mog2.94","article-title":"Extracellular vesicles in cancer drug resistance: Mechanistic insights and therapeutic implications","volume":"3","author":"Zuo","year":"2024","journal-title":"MedComm-Oncology"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:15:12Z","timestamp":1793632512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2162253126002878"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103116","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into extracellular vesicles: From biogenesis and tumor immune modulation to their clinical potential in immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103116"}}